David Greco

3.5k total citations
8 papers, 411 citations indexed

About

David Greco is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, David Greco has authored 8 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in David Greco's work include Immune cells in cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). David Greco is often cited by papers focused on Immune cells in cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). David Greco collaborates with scholars based in United States, Austria and Germany. David Greco's co-authors include Monique E. De Paepe, Quanfu Mao, Zain Fanek, Oleg Butovsky, Ron Cialic, Anna M. Krichevsky, Mark P. Jedrychowski, Nathalie Pochet, Hans Lassmann and Merit Cudkowicz and has published in prestigious journals such as Cancer Research, Annals of Neurology and Journal of Chromatography A.

In The Last Decade

David Greco

7 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Greco United States 4 152 119 91 70 68 8 411
Makoto Hayase Japan 8 99 0.7× 153 1.3× 69 0.8× 42 0.6× 45 0.7× 31 429
Kinga Blecharz Germany 10 199 1.3× 173 1.5× 161 1.8× 55 0.8× 41 0.6× 11 506
Marine Poittevin France 10 179 1.2× 132 1.1× 50 0.5× 32 0.5× 119 1.8× 11 472
Huabin Gao China 13 77 0.5× 310 2.6× 84 0.9× 165 2.4× 58 0.9× 28 523
Elisa Maggioli Italy 7 113 0.7× 190 1.6× 63 0.7× 21 0.3× 87 1.3× 8 399
Huachen Huang China 9 172 1.1× 130 1.1× 67 0.7× 38 0.5× 79 1.2× 14 389
Xiao-Yi Xiong China 4 78 0.5× 118 1.0× 152 1.7× 23 0.3× 49 0.7× 5 305
Christopher Qian China 11 53 0.3× 118 1.0× 67 0.7× 43 0.6× 25 0.4× 14 365
Jishu Xian China 12 71 0.5× 184 1.5× 80 0.9× 88 1.3× 37 0.5× 29 384
Poulomi Banerjee India 10 73 0.5× 144 1.2× 68 0.7× 44 0.6× 29 0.4× 12 323

Countries citing papers authored by David Greco

Since Specialization
Citations

This map shows the geographic impact of David Greco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Greco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Greco more than expected).

Fields of papers citing papers by David Greco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Greco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Greco. The network helps show where David Greco may publish in the future.

Co-authorship network of co-authors of David Greco

This figure shows the co-authorship network connecting the top 25 collaborators of David Greco. A scholar is included among the top collaborators of David Greco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Greco. David Greco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Qi, Yilin, Jun Kuai, Yingzhi Bi, et al.. (2023). Abstract LB337: Inhibition of the E3 ligase CBL-B enhances the effector function and proliferation of natural killer cells. Cancer Research. 83(8_Supplement). LB337–LB337. 1 indexed citations
2.
Qi, Yilin, Jun Kuai, Yingzhi Bi, et al.. (2022). 424 An allosteric, orally administered CBL-B inhibitor remodels the tumor microenvironment and enhances immune-mediated tumor growth inhibition. Regular and Young Investigator Award Abstracts. A445–A445.
3.
Butovsky, Oleg, Mark P. Jedrychowski, Ron Cialic, et al.. (2015). ISDN2014_0028: REMOVED: Targeting miR‐155 restores dysfunctional microglia and ameliorates disease in the SOD1 model of ALS. International Journal of Developmental Neuroscience. 47(Part_A). 5–5. 2 indexed citations
4.
Madore, Charlotte, Zain Fanek, David Greco, et al.. (2014). Dysregulation of the homeostatic microglia signature in germ-free mice. Journal of Neuroimmunology. 275(1-2). 161–161. 2 indexed citations
5.
Butovsky, Oleg, Mark P. Jedrychowski, Ron Cialic, et al.. (2014). Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice. Annals of Neurology. 77(1). 75–99. 285 indexed citations
6.
Paepe, Monique E. De, Steven K. Shapiro, David Greco, et al.. (2010). Placental markers of twin-to-twin transfusion syndrome in diamniotic–monochorionic twins: A morphometric analysis of deep artery-to-vein anastomoses. Placenta. 31(4). 269–276. 52 indexed citations
7.
Paepe, Monique E. De, David Greco, & Quanfu Mao. (2010). Angiogenesis-related gene expression profiling in ventilated preterm human lungs. Experimental Lung Research. 36(7). 399–410. 65 indexed citations
8.
Conway, Walter D., et al.. (1989). Purification of nitrophenylvaleric acid reaction mixtures by counter-current chromatography. Journal of Chromatography A. 484. 391–397. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026